Author: Behrous Davani
Behrous managed Institutional Development Award (IDeA) Centers of Biomedical Research Excellence (COBRE), Science Education Partnership Awards (SEPA), and the Native American Research Centers for Health (NARCH) programs prior to moving to the National Cancer Institute in April 2022.
Posts by Behrous Davani
UPDATE: The webinar video and slides [PDF] have been posted.
We’re pleased to announce that the IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) funding announcement (RFA-GM-22-001) has been issued. The purpose of this initiative is to provide support for eligible small business concerns in each of the IDeA regions (Central, Northeast, Southeast, and West) to develop educational products promoting biomedical entrepreneurship in IDeA-eligible states. These products are expected to help academic institutions in these states translate scientific discoveries and technologies from research laboratories into commercial products.
The application due date is January 5, 2022.
Continue reading “IDeA Regional Entrepreneurship Development Funding Announcement and Upcoming Webinar”
UPDATE: The video from this webinar is now available.
We were unable to get together in person for this year’s Native American Research Centers for Health (NARCH) program meeting. Instead, we’re hosting a virtual meeting for NARCH investigators, project directors, and community leaders:
Friday, December 11, 1:30-5:45 p.m. ET
Continue reading “Join Our Virtual NARCH Program Meeting”
We’ve joined the NIH Office of the Director and several institutes in two Rapid Acceleration of Diagnostics Radical (RADx-rad) initiative funding opportunity announcements (FOAs). These FOAs offer an excellent opportunity for NIGMS-supported researchers with expertise in technology development and/or artificial intelligence/machine learning to conduct innovative research addressing the public health emergency caused by COVID-19.
Continue reading “Funding Opportunities: Rapid Acceleration of Diagnostics Radical (RADx-rad) Emergency Awards”
We’d like to call your attention to a pair of recently published notices (NOT-GM-20-042 and NOT-GM-20-043) that address the unfavorable impact of the COVID-19 pandemic on institutions’ ability to recruit faculty investigators. In response to this, we’ve reduced the minimum number of research projects required for our Centers of Biomedical Research Excellence (COBRE) Phases 1 and 2 from three to two. Additionally, we’ll allow budget increases for recruitment costs and pilot projects. These changes apply to active awards and to applications submitted for new Phase 1 (PAR-19-313) and Phase 2 (PAR-19-312) funding opportunity announcements.
Continue reading “Changes to COBRE Phase 1 and Phase 2 Awards and Applications”
